>_ QFI Terminal
Terminal › Stocks › IDXX

IDEXX Laboratories, Inc. (IDXX) Stock

Healthcare · Medical - Diagnostics & Research · US
$702.59 +0.85%
Last updated Nov 12, 2026 09:21 UTC

IDXX Key Statistics

Market Cap$55.35B
P/E (TTM)47.37
P/S (TTM)11.87
P/B (TTM)29.63
Revenue (TTM)$4.66B
EPS (TTM)$14.83
Dividend Yield—
ROE (TTM)71.18%
Net Margin25.36%
Gross Margin62.72%
52W High$769.98
52W Low$500.61
Analyst ViewBuy
Price Target$716.67
Employees11,000
Volume422,828

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

CEO: Michael Erickson. Company website

IDXX — Frequently Asked Questions

What is the IDXX stock price today?

IDEXX Laboratories, Inc. (IDXX) trades at $702.59, up 0.85% on the day, as of Nov 12, 2026 09:21 UTC.

What is IDEXX Laboratories, Inc.'s market cap?

IDEXX Laboratories, Inc. has a market capitalisation of $55.35B, calculated from the live IDXX share price and shares outstanding.

What is the P/E ratio of IDXX?

IDXX trades at a trailing P/E of 47.37, from earnings per share of $14.83 over the last twelve months.

How much revenue does IDEXX Laboratories, Inc. make?

IDEXX Laboratories, Inc. generated revenue of $4.66B over the trailing twelve months, which puts the stock at 11.87 times sales.

What is the 52-week range for IDXX?

IDXX has traded between $500.61 and $769.98 over the past 52 weeks, and the last price is 8.8% below that high.

Is IDEXX Laboratories, Inc. profitable?

Yes. IDEXX Laboratories, Inc. keeps 25.36% of revenue as net income over the trailing twelve months.

What is the analyst price target for IDXX?

Wall Street analysts rate IDXX Buy, with an average price target of $716.67, 2.0% above the current price.

What sector is IDEXX Laboratories, Inc. in?

IDEXX Laboratories, Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.

Who is the CEO of IDEXX Laboratories, Inc.?

Michael Erickson is the chief executive of IDEXX Laboratories, Inc., which employs 11,000 people.

Where can I track IDXX in real time?

QFI Terminal shows IDXX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See IDXX live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open IDXX in Terminal See plans

Medical - Diagnostics & Research stocks

TMO Thermo Fisher Scientific Inc. DHR Danaher Corporation IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. WAT Waters Corporation ILMN Illumina, Inc. MTD Mettler-Toledo International Inc. CRL Charles River Laboratories International, Inc. EXAS Exact Sciences Corporation RVTY Revvity, Inc. NTRA Natera, Inc. MEDP Medpace Holdings, Inc. QGEN Qiagen N.V. GH Guardant Health, Inc. SHC Sotera Health Company MYGN Myriad Genetics, Inc. NEO NeoGenomics, Inc. NOTV Inotiv, Inc. OPK OPKO Health, Inc. ATLN Atlantic International Corp. CDNA CareDx, Inc

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

ETFs holding IDXX

XLV State Street Health Care Select Sector SPDR ETF 0.81% QUAL iShares MSCI USA Quality Factor ETF 0.35% RSP Invesco S&P 500 Equal Weight ETF 0.26% QQQ Invesco QQQ Trust, Series 1 0.25% QQQM Invesco NASDAQ 100 ETF 0.25% SCHG Schwab U.S. Large-Cap Growth ETF 0.15% IWF iShares Russell 1000 Growth ETF 0.15% TQQQ ProShares UltraPro QQQ 0.15% VUG Vanguard Morningstar Growth ETF 0.13% SPY State Street SPDR S&P 500 ETF 0.09% IVV iShares Core S&P 500 ETF 0.08% SCHX Schwab U.S. Large-Cap ETF 0.08% IWB iShares Russell 1000 ETF 0.08% SCHB Schwab U.S. Broad Market ETF 0.07% FB ProShares S&P 500 Dynamic Buffer ETF 0.07% VOO Vanguard S&P 500 ETF 0.06% VTI Vanguard Morningstar Total Stock Market ETF 0.06% ACWI iShares MSCI ACWI ETF 0.05% UPRO ProShares - UltraPro S&P500 0.05% FNDX Schwab Fundamental U.S. Large Company ETF 0.04% VT Vanguard Total World Stock ETF 0.04% IWD iShares Russell 1000 Value ETF 0.02% SPXL Direxion Daily S&P 500 Bull 3X Shares 0.02%

Largest institutional holders of IDXX

BlackRock, Inc. BLK 8,170,178 shares
VANGUARD CAPITAL MANAGEMENT LLC 5,152,213 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 3,896,521 shares
STATE STREET CORP STT 3,748,660 shares
Invesco Ltd. IVZ 3,611,416 shares
GEODE CAPITAL MANAGEMENT, LLC 2,620,703 shares
BAMCO INC /NY/ 1,976,778 shares
MORGAN STANLEY MS 1,356,103 shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1,067,078 shares
Fundsmith LLP 1,019,887 shares

IDXX insiders on other boards

DGX Quest Diagnostics Incorporated Samad Sam PODD Insulet Corp. Mazelsky Jonathan Jay XRAY DENTSPLY SIRONA Inc. Mazelsky Jonathan Jay CIEN Ciena Corporation Claflin Bruce L. DBX Dropbox, Inc. Peacock Karen VSXY Victoria's Secret & Company Britt Irene Chang IART Integra LifeSciences Holdings Corporation Essig Stuart RVTY Revvity, Inc. Vandebroek Sophie V. PII Polaris Inc. Kingsley Lawrence D APTV Aptiv PLC Hooley Joseph L XOM Exxonmobil Holdings Corporation Hooley Joseph L VEEV Veeva Systems Inc. Hunt Nimrata